SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : The 56 Point TA; Charts With an Attitude -- Ignore unavailable to you. Want to Upgrade?


To: Hank who wrote (12477)2/19/1998 4:58:00 PM
From: Braddock Bull  Read Replies (1) | Respond to of 79296
 
Zona looks ripe

Hank, I know they're are a ton of shorts on Zona, and for good reason it seems. The stock appears to be teetering on this little plateau here around $20 3/4. There sure is alot of questionable stuff flying around about Zona.. the last thing I read suggested dubious results in their Phase III trials (of their only product). Muse has long been approved, it's reasonably effective... (vvus is oversold big time). Viagra is over-hyped, but everybody thinks it will impact the market pretty dramatically and approval looks set for March. Now correct me if I'm wrong... Zona has no product (yet) and no revenues, they're racing to get some results to the FDA before Viagra, and the results are questionable?? I think you got one here!

Brad